ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1898

Repression Of Wolf-Hischhorn Syndrome Candidate-1 (WHSC1) Contributes To The Osteoarthritis-Inducing Cartilage Loss Of Functions

Francisco Espinoza1, Yves-Marie Pers2, Paul Chuchana3, Jean Marc Brondello4 and Christian Jorgensen2, 1INSERM U844, MONTPELLIER, France, 2Department of therapy & Immuno-Rhumatology, Inserm U844, CHU saint-Eloi, Université Montpellier 1, CHU Lapeyronie, Montpellier, France, 3INSERM U844, Montpellier, France, 4Inserm U844, UM1, Montpellier, France

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: cartilage, epigenetics and osteoarthritis, Senescent Cells

  • Tweet
  • Email
  • Print
Session Information

Title: Genetics and Genomics of Rheumatic Disease II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Accumulation of senescent p16INK4A-positive cells within numerous tissues through out life span contributes to the onset of several age-related disease such as intervertebral disc degenerescence or osteoarthritis (OA). These cells are believed to induce tissue degenerescence and age-dependent loss of functions through the establishment of one senescence-associated secretory phenotype (SASP) including pro-inflammatory cytokines (e.g IL-6, IL-8) and hypertrophic-associated matrix degrading enzymes (e.g MMP1/13 and ADAMTS5). Understanding the molecular mechanism in particular epigenetic regulators leading to the establishment of such deleterious secretome, is a next challenge. Here, we investigate the role and the regulation of the histone H3K36Me2 methyltranferase, WHSC1 (NSD2/MMSET) in cartilage loss of functions in OA.

Methods: We used primary human OA chondrocytes, specific siRNA interference, western-blot, transient transfection, IL-1b treatment, RT-qPCR, Elisa and statistical analysis.

Results: We found that WHSC1 mRNA expression is reduced in OA senescent-like cartilage compared to healthy donors. WHSC1 mRNA and protein levels are as well reduced in human primary chondrocytes following IL-1b chronic treatment. By a loss of function experiment based on specific siRNA against WHSC1, we found an up-regulation of MMP1, MMP13 and ADAMTS5 mRNA accumulation but not pro-inflammatory cytokines (IL-8, IL-6) in primary chondrocytes. As result, WHSC1-depleted chondrocytes show a reduced expression in Aggrecan and a slight increase production in GAG.

Conclusion:

Our preliminary data demonstrate that WHSC1 impacts articular homeostasis maintenance by repressing part of the senescence-associated secretome induced in OA. Further experiments are required in particular for understanding how WHSC1-dependent epigenetic regulation of these hypertrophic-associated matrix-remodeling factors, occurs.


Disclosure:

F. Espinoza,
None;

Y. M. Pers,
None;

P. Chuchana,
None;

J. M. Brondello,
None;

C. Jorgensen,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/repression-of-wolf-hischhorn-syndrome-candidate-1-whsc1-contributes-to-the-osteoarthritis-inducing-cartilage-loss-of-functions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology